Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

A 3-year-old pug in Mumbai received a continuous glucose monitor to track his high blood sugar levels. The CGM sensor, linked ...

Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...

SiBionics announced today that it unveiled its GS3 continuous glucose monitor (CGM), which now has CE mark approval.

A real-world analysis showed a link between continuous glucose monitor (CGM) distribution channel and outcomes for patients with diabetes.

CGMs are transforming health tracking for non-diabetics, providing insights into glucose levels and influencing dietary choices and athletic performance.

The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...

Nanowear, a leader in home-based cardiometabolic digital diagnostics announced that SimpleSense™, a nanotechnology-enabled wearable, mobile and software diagnostics platform, will ingest glucose data ...

ATTD conference, experts debated whether patients who use continuous glucose monitoring should aim for normal glycemia.

Users of Abbott’s CGM device can now view data and gain additional insights through Glooko’s diabetes management platform.

In a new study in the journal Diabetes Technology & Therapeutics (DTT), investigators evaluated the accuracy of the 15.5-day ...